Company Profile
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company provides the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices in Mainland China and globally.
The company offers Guyoudao, a bone repair material. Its portfolio also includes Jilifen, a human granulocyte colony stimulating factor injection, Jijufen, a human interleukin-11 injection, Jiouting, a palonosetron hydrochloride injection, Jifuwei, a fulvestrant injection, Jitansu, a fosaprepitant dimeglumine injection, and Jixinfen, PEG-GยCSF injection
Jilixin avatrombopag maleate tablets. Its portfolio also includes Jipailin, a low molecular weight heparin sodium injection, and Yinuojia, an enoxaparin sodium injection. Incorporated in 1993 and headquartered in Hangzhou, China, Hangzhou Jiuyuan Genetic Biopharmaceutical was formerly known as Hangzhou Jiuyuan Gene Engineering Co., Ltd. before rebranding in April 2025.